Albion Financial Group’s Merck MRK Stock Holding History

Albion Financial Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.92M	Buy	30,544 +239	+0.8%	+$28K	0.23%	71
2026 Q1	$3.65M	Sell	30,305 -179	-0.6%	-$20.7K	0.24%	72
2025 Q4	$3.21M	Sell	30,484 -5,859	-16%	-$550K	0.2%	72
2025 Q3	$3.05M	Buy	36,343 +1,016	+3%	+$83.7K	0.18%	73
2025 Q2	$2.8M	Buy	35,327 +3,182	+10%	+$253K	0.18%	77
2025 Q1	$2.89M	Sell	32,145 -12,706	-28%	-$1.19M	0.2%	77
2024 Q4	$4.46M	Sell	44,851 -4,102	-8%	-$423K	0.31%	64
2024 Q3	$5.56M	Buy	48,953 +688	+1%	+$81.7K	0.39%	55
2024 Q2	$5.98M	Buy	48,265 +333	+0.7%	+$42.9K	0.45%	48
2024 Q1	$6.32M	Sell	47,932 -227	-0.5%	-$28K	0.49%	45
2023 Q4	$5.25M	Buy	48,159 +911	+2%	+$94.6K	0.43%	49
2023 Q3	$4.86M	Buy	47,248 +5,205	+12%	+$561K	0.45%	48
2023 Q2	$4.85M	Buy	42,043 +403	+1%	+$45.8K	0.42%	53
2023 Q1	$4.43M	Sell	41,640 -1,265	-3%	-$137K	0.41%	55
2022 Q4	$4.76M	Buy	42,905 +1,872	+5%	+$191K	0.46%	50
2022 Q3	$3.53M	Buy	41,033 +777	+2%	+$69.4K	0.36%	60
2022 Q2	$3.67M	Buy	40,256 +6,268	+18%	+$556K	0.36%	61
2022 Q1	$2.79M	Buy	33,988 +14,824	+77%	+$1.17M	0.24%	73
2021 Q4	$1.47M	Sell	19,164 -1,417	-7%	-$113K	0.12%	100
2021 Q3	$1.55M	Buy	20,581 +2,182	+12%	+$166K	0.14%	98
2021 Q2	$1.43M	Buy	+18,399	New	+$1.37M	0.12%	104
2020 Q4	$516K	Buy	6,611 +2,050	+45%	+$157K	0.05%	140
2020 Q3	$361K	Sell	4,561 -602	-12%	-$47.2K	0.04%	168
2020 Q2	$381K	Sell	5,163 -63	-1%	-$4.74K	0.05%	162
2020 Q1	$384K	Buy	5,226 +63	+1%	+$4.95K	0.06%	147
2019 Q4	$448K	Buy	5,163 +316	+7%	+$26K	0.05%	148
2019 Q3	$389K	Sell	4,847 -20,646	-81%	-$1.65M	0.05%	152
2019 Q2	$2.04M	Buy	25,493 +324	+1%	+$24.8K	0.26%	67
2019 Q1	$2M	Sell	25,169 -229	-0.9%	-$17.1K	0.27%	66
2018 Q4	$1.85M	Sell	25,398 -48,162	-65%	-$3.4M	0.29%	66
2018 Q3	$4.98M	Sell	73,560 -3,599	-5%	-$229K	0.67%	34
2018 Q2	$4.47M	Buy	77,159 +11,551	+18%	+$652K	0.64%	35
2018 Q1	$3.41M	Buy	65,608 +1,835	+3%	+$99.1K	0.52%	43
2017 Q4	$3.42M	Sell	63,773 -6,991	-10%	-$388K	0.52%	43
2017 Q3	$4.32M	Sell	70,764 -219	-0.3%	-$13.3K	0.66%	37
2017 Q2	$4.34M	Sell	70,983 -110	-0.2%	-$6.7K	0.72%	34
2017 Q1	$4.31M	Sell	71,093 -1,108	-2%	-$67.2K	0.65%	35
2016 Q4	$4.06M	Buy	72,201 +4,684	+7%	+$274K	0.67%	34
2016 Q3	$4.02M	Buy	67,517 +4,337	+7%	+$254K	0.69%	38
2016 Q2	$3.47M	Buy	63,180 +1,441	+2%	+$76.7K	0.62%	32
2016 Q1	$3.12M	Buy	61,739 +2,126	+4%	+$104K	0.53%	34
2015 Q4	$3M	Sell	59,613 -11,102	-16%	-$560K	0.52%	35
2015 Q3	$3.33M	Buy	70,715 +556	+0.8%	+$29.5K	0.6%	29
2015 Q2	$3.81M	Buy	70,159 +694	+1%	+$38.9K	0.63%	29
2015 Q1	$3.81M	Buy	69,465 +29,451	+74%	+$1.67M	0.65%	29
2014 Q4	$2.17M	Buy	40,014 +877	+2%	+$48.9K	0.37%	39
2014 Q3	$2.21M	Sell	39,137 -277	-0.7%	-$15.6K	0.39%	39
2014 Q2	$2.18M	Sell	39,414 -389	-1%	-$21.2K	0.38%	44
2014 Q1	$2.16M	Buy	39,803 +1,142	+3%	+$59.1K	0.4%	44
2013 Q4	$1.85M	Buy	38,661 +4,517	+13%	+$206K	0.35%	46
2013 Q3	$1.55M	Buy	34,144 +2,174	+7%	+$99.3K	0.33%	46
2013 Q2	$1.42M	Buy	+31,970	New	+$1.43M	0.31%	47

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Albion Financial Group's MRK Position: Q2 2026 in Review

Albion Financial Group increased its Merck (MRK) stake by 0.79% in Q2 2026, buying an estimated $28K and bringing the position to 30,544 shares worth $3.92M. The position accounts for 0.23% of the portfolio, ranked #71.

Albion Financial Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.32M in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Albion Financial Group held 30,544 shares of Merck worth $3.92M as of Q2 2026.
Albion Financial Group bought 239 Merck shares in Q2 2026, an estimated $28K.
Merck made up 0.23% of Albion Financial Group's portfolio in Q2 2026, its #71 holding.
Albion Financial Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Albion Financial Group's Merck position peaked at $6.32M in Q1 2024.
1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.